research grade peptides FAQ

Verify three variables before concluding the peptide is inactive: administration technique, baseline cortisol levels, and OXTR genotype. Improper nasal spray technique (spraying into the throat instead of upper nasal passages) reduces olfactory nerve uptake by 60%. Subjects with chronically elevated baseline cortisol (above 15 µg/dL) demonstrate blunted oxytocin receptor sensitivity. OXTR rs53576 AA genotype carriers show 35–50% weaker anxiolytic responses compared to GG carriers. If all three check out and the peptide was stored correctly, consider dose escalation to 48–60 IU or switching to a different synthesis batch with fresh CoA verification.

Discard it and prepare a fresh solution. Even 8–12 hours at room temperature (20–25°C) allows partial oxidation of the disulfide bond between cysteine residues, reducing receptor binding affinity by 30–50%. The peptide may appear visually identical, but the molecular structure has degraded. Oxytocin lacks a visual indicator of potency loss, which is why strict temperature control is non-negotiable. When in doubt, reconstitute fresh rather than risk compromised data.

Dissolve a small test quantity (0.5–1 mg) in sterile water and visually inspect for clarity. Functional SS-31 should dissolve completely within 2–3 minutes of gentle agitation, forming a clear to slightly opalescent solution with no visible particulates. If the solution remains cloudy, contains floating aggregates, or shows color (yellow, brown, or pink tints), the peptide has likely undergone oxidative degradation or moisture absorption during storage. Contact your supplier immediately with photographic documentation. Reputable suppliers replace compromised batches at no cost. Do not proceed with experiments using visibly degraded peptide; oxidized SS-31 produces inconsistent results and introduces uncontrolled variables into mitochondrial targeting assays.

Request it before purchase. If they can't provide MS data, you cannot confirm the peptide sequence is correct. HPLC tells you the sample is pure but not what it's pure of. Deletion sequences (peptides missing one or more amino acids) often co-elute with the target peptide or elute as nearby peaks that don't significantly lower HPLC purity percentage, but they are structurally distinct molecules with altered or absent bioactivity. Mass spectrometry is the only analytical method that definitively confirms molecular weight and therefore amino acid sequence. A peptide sold as PE-22-28 without MS verification could be a closely related analog, a deletion sequence, or even an entirely different peptide that happens to have similar HPLC retention time. Our PE 22 28 includes MS confirmation within ±1 Da of expected mass in every batch-specific CoA.

Do not proceed with that supplier. Batch-specific MS data is the only definitive proof that the peptide sequence matches SS-31's structure. Without it, you have no verification that dimethyltyrosine was incorporated or that the four-residue sequence is correct. Generic certificates referencing "representative batches" or historical data from different synthesis runs are insufficient for research-grade work. The best SS-31 supplier includes MS data as standard documentation, not a premium service. If your current supplier cannot provide it, switch to a vendor who can. The cost of using mislabeled or degraded peptide far exceeds the cost of sourcing from a verified supplier.

Verify the supplier provides synthesis method disclosure, analytical method validation, and stability data under ICH guidelines. Regulatory submissions and GLP-compliant studies require complete characterization of all research materials, including peptide source, synthesis and purification methods, purity determination methods, impurity profiles, and stability under stated storage conditions. Real Peptides maintains documentation packages for all peptides that include synthesis protocol (SPPS with specified coupling reagents and protecting groups), purification method (preparative HPLC with gradient details), analytical methods (HPLC method with column type, mobile phase, gradient, and detection wavelength; MS method with ionization mode and mass range), and accelerated stability data showing degradation rates at −20°C, 4°C, and 25°C over 12 months. This level of documentation is uncommon among research peptide suppliers but is mandatory for regulatory-grade work.

Check peptide content by amino acid analysis, not just HPLC purity. HPLC measures relative abundance of UV-absorbing species but doesn't distinguish peptide mass from non-peptide mass like trifluoroacetic acid (TFA) counterions or residual moisture. A peptide with 98% HPLC purity may contain only 85% actual peptide if the remaining 13% is TFA salts carried over from purification. TFA doesn't absorb at 220nm so it doesn't appear in HPLC chromatograms, but it does contribute to vial weight. If you weigh 10mg and assume it's 98% peptide, you may actually have only 8.5mg active compound. This shortfall directly reduces assay performance in dose-response experiments or receptor binding studies where precise molar concentrations are required. Real Peptides reports both HPLC purity and peptide content by AAA so you know exactly how much bioactive peptide you're reconstituting.

Order SS-31 in small vials (1–5 mg) matched to your monthly usage rate rather than one large vial for the entire study. Reconstitute only what you will use within 7–10 days, keeping the remaining lyophilized powder at −20°C until needed. This approach eliminates concentration drift caused by degradation of bulk reconstituted stock and ensures each dosing window uses freshly prepared peptide at verified purity. For multi-month studies, many researchers also request peptides from the same production batch for all timepoints. This minimizes inter-batch variability that could confound longitudinal data.

Yes. In vivo applications require endotoxin testing in addition to standard purity analysis, as even trace lipopolysaccharide (LPS) contamination from bacterial sources can trigger inflammatory responses that confound experimental outcomes. Request a certificate of analysis confirming endotoxin levels below 1 EU/mg (endotoxin units per milligram), measured by LAL (Limulus Amebocyte Lysate) assay. Most peptide suppliers do not test for endotoxin unless specifically requested; researchers conducting animal studies should verify this before ordering. Real Peptides provides endotoxin testing on request for all peptides intended for in vivo work. Ensuring your mitochondrial research is not confounded by immune activation artifacts.

Contact the supplier immediately and request re-shipment with confirmed cold chain. Temperature excursions above 25°C for more than 6–8 hours cause irreversible oxidation of methionine residues in PE-22-28, converting Met to Met-sulfoxide, which alters peptide structure and reduces receptor binding affinity. This degradation is not reversible and cannot be detected visually. The lyophilized powder looks identical whether intact or oxidized. HPLC analysis would show additional peaks corresponding to oxidized species, but most researchers don't have in-house HPLC access to verify. The only reliable safeguard is cold chain shipping with temperature monitoring. Real Peptides ships all peptides with gel ice packs in insulated packaging and provides tracking showing shipment occurred within 24 hours of order to minimize transit time.

Request the CoA for your exact order's batch number within 24 hours. If the supplier provides a generic spec sheet instead, that peptide did not undergo individual verification. You're receiving material based on assumed compliance from aggregated inventory. Functional consequence: your dose-response data may not replicate when colleagues order the same peptide from verified sources. Switch to a limitless life alternative that conducts per-batch testing or plan to run your own potency verification assays before committing material to experiments.

Run a fresh potency verification assay comparing your current stock to newly synthesized material from the same supplier. If activity discrepancy exceeds 10%, degradation has occurred either during storage or from initial purity issues. Check storage conditions first: lyophilized peptides stored above −20°C or in frost-free freezers lose potency cumulatively. If storage was correct, request a replacement batch and compare the new Certificate of Analysis to your original order. Purity variance between batches is the likely cause. A functional limitless life alternative eliminates this variable through verified small-batch synthesis.

Measure storage temperature immediately upon package opening if possible. If peptides spent >48 hours above 8°C, degradation has begun. Susceptible compounds lose 8–12% potency through oxidative damage and hydrolysis. Do not assume powder appearance indicates integrity. Contact the supplier for replacement under cold-chain guarantee terms. For ongoing orders, request temperature data loggers or switch to a supplier offering insulated shipping with extended cold-pack ratings. Real Peptides includes 48–72 hour cold-chain protection as standard, not as a surcharge.

Request the certificate of analysis and verify mass spectrometry data is included. If it's not, the peptide's sequence was never independently confirmed. Switch to a purerawz alternative using small-batch SPPS with mandatory mass spec verification before re-running the assay. Sequence variants and truncated peptides bind receptors at different affinities, producing dose-response curves that don't match published data.

Order your entire study supply from one production batch and store it at −20°C in desiccated conditions. Batch reservation services allow you to lock inventory from a single synthesis lot, eliminating batch-to-batch variance across study phases. For peptides prone to aggregation like SLU PP 332, this consistency is critical. Even 3% purity variance between batches can shift receptor binding curves enough to affect statistical significance in longitudinal data. Confirm batch reservation availability before committing to a supplier.

Endotoxin contamination above 1.0 EU/mg activates toll-like receptor 4 (TLR4) signaling in cell cultures, elevating cytokines like IL-6 and TNF-α in control groups. If your supplier doesn't test endotoxin levels, inflammatory pathway studies become unreliable. Request endotoxin specs explicitly. Suppliers omitting this data are either not testing or failing to meet research-grade thresholds.

Large-batch suppliers aliquot from master synthesis runs stored at −20°C, where lyophilized peptides degrade 2–5% annually. Small-batch synthesis eliminates storage degradation as a variable. Each order is freshly synthesized within weeks of shipping. For longitudinal studies, specify a purerawz alternative that synthesizes on-demand rather than from inventory, ensuring every phase uses peptides with equivalent purity profiles.

Assume 20–30% potency loss and adjust your protocol accordingly or discard the vial. An 8-hour exposure at 22°C initiates measurable degradation, though the peptide isn't completely inactivated. If the research timeline allows variability, continue with the understanding that results may show reduced magnitude. If the study requires precise dosing consistency, discard and start fresh. Temperature-induced degradation is cumulative. A vial exposed once and returned to refrigeration will degrade faster during subsequent exposures than a vial maintained at constant cold-chain temperature.

Discard it immediately. Cloudiness indicates either bacterial contamination or protein aggregation. Both render the solution unusable. Bacteriostatic water prevents most bacterial growth, but peptides stored in non-sterile conditions or drawn with reused needles can still develop colonies. Protein aggregation occurs when amino acids clump together after partial denaturation, typically from repeated temperature fluctuations during storage. Neither condition is reversible, and administering degraded peptide introduces uncontrolled variables that invalidate experimental results.

The peptide is no longer reliable. Freezing forms ice crystals that physically disrupt the amino acid chain. When the solution thaws, the structure doesn't reassemble correctly. Some molecules remain intact, others fragment, creating a mixture of active and inactive peptide that cannot be quantified. Visual inspection won't detect this. The solution looks clear and normal. Discard and reconstitute a fresh vial. Our team has seen researchers attempt to salvage frozen peptides by warming slowly or centrifuging. These interventions don't work.